4//SEC Filing
Mirabelli Christopher 4
Accession 0001104659-24-106331
CIK 0001509745other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:23 PM ET
Size
5.9 KB
Accession
0001104659-24-106331
Insider Transaction Report
Form 4
Mirabelli Christopher
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-02+85,000→ 85,000 totalExercise: $2.45Exp: 2034-10-02→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of October 2, 2024.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001262326
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:23 PM ET
- Size
- 5.9 KB